Smith Patrick F
- SEC CIK
- 0001890360
No open-market purchases or sales filed in the past year.
Current role at each company
- CERT Certara, Inc.PRESIDENT, DRUG DEV SOLUTIONSas of Oct 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Smith Patrick F as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2024 (view filing) | Oct 7 | 1 day | Smith Patrick FPRESIDENT, DRUG DEV SOLUTIONS | SSale | −5.41K | $11.03 | −$59.7K | −9.7%50.1K after | 10b5-1 |
| Apr 4, 2024 (view filing) | Apr 2 | 2 days | Smith Patrick FPRESIDENT, DRUG DEV SOLUTIONS | SSale | −14.4K | $16.85 | −$243.2K | −22.4%50.1K after | 6 lots10b5-1 |
| Feb 21, 2024 (view filing) | Feb 20 | 1 day | Smith Patrick FPRESIDENT, DRUG DEV SOLUTIONS | SSale | −5.00K | $18.00 | −$90.0K | −8.3%55.0K after | 10b5-1 |
| Jun 6, 2023 (view filing) | Jun 5 | 1 day | Smith Patrick FPRESIDENT, INTEGRATED DRUG DEV | SSale | −19.1K | $21.55 | −$411.7K | −24.2%60.0K after | 10b5-1 |
| Nov 14, 2022 (view filing) | Nov 9 | 5 days | Smith Patrick FPRESIDENT, INTEGRATED DRUG DEV | SSale | −2.39K | $13.48 | −$32.2K | −3.1%74.9K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Smith Patrick FPRESIDENT, INTEGRATED DRUG DEV | SSale | −10.0K | $17.71 | −$177.1K | −11.3%78.5K after | |
| Jun 9, 2022 (view filing) | Jun 8 | 1 day | Smith Patrick FPRESIDENT, INTEGRATED DRUG DEV | SSale | −10.0K | $19.16 | −$191.6K | −10.2%88.5K after | |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Smith Patrick FPRESIDENT, INTEGRATED DRUG DEV | SSale | −3.35K | $22.29 | −$74.7K | −3.3%98.5K after |